The Company is a Korea-based company principally engaged in the development and supply of medical software. The Company is principally engaged in the development and supply of medical software such as cancer diagnostic aid solutions, cancer early detection solutions, cancer risk prediction solutions and others through artificial intelligence (AI) technologies. The Company was established on August 23, 2013. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on July 21, 2022.
Headquarters
4F 374Gangnam-Daero, Gangnam-Gu
Seoul; Seoul;
Contact Details: Purchase the Lunit Inc. (Seoul) report to view the information.
Website: http://www.lunit.io
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service